Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

3.5K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.5K
Hypertension I: Introduction01:28

Hypertension I: Introduction

562
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
562
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

364
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
364
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

613
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
613
Stereotypes, Prejudice, and Discrimination02:55

Stereotypes, Prejudice, and Discrimination

94.6K
Humans are very diverse and although we share many similarities, we also have many differences. The social groups we belong to help form our identities (Tajfel, 1974). These differences may be difficult for some people to reconcile, which may lead to prejudice toward people who are different. Prejudice is a negative attitude and feeling toward an individual based solely on one’s membership in a particular social group (Allport, 1954; Brown, 2010). Prejudice is common against people who...
94.6K
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

6.2K
Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Overcoming barriers to early diagnosis and treatment of p.Val142Ile amyloid transthyretin (ATTR) cardiomyopathy.

Heart failure reviews·2026
Same author

Enhancing representation in cardiovascular trials: Lessons from Lp(a)FRONTIERS EXPANSION in United States Black and Hispanic patients with elevated lipoprotein(a) and established atherosclerotic cardiovascular disease.

American journal of preventive cardiology·2026
Same author

Cuts to medicaid and the affordable care act: Negative consequences for the black community.

Journal of the National Medical Association·2026
Same author

Correction to: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Circulation·2026
Same author

Medicaid work requirements and cost-sharing under H.R.1: Implications for structurally vulnerable and medically complex populations in New Orleans.

Journal of the National Medical Association·2026
Same author

Correction to: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Hypertension (Dallas, Tex. : 1979)·2026

Related Experiment Video

Updated: Dec 21, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

1.1K

Hypertension and race/ethnicity.

Bradley P Deere1, Keith C Ferdinand

  • 1Tulane University School of Medicine, New Orleans, LA, USA.

Current Opinion in Cardiology
|May 14, 2020
PubMed
Summary

Racial/ethnic minorities face higher hypertension risks and outcomes. Addressing social determinants and using team-based interventions are key to reducing these health disparities.

Area of Science:

  • Public Health
  • Genetics
  • Health Disparities

Background:

  • Racial/ethnic minorities in the U.S. experience disproportionately high rates of hypertension (HTN) morbidity and mortality.
  • Despite advances in genomics, understanding HTN disparities is limited by underrepresentation in studies.
  • Social determinants of health are increasingly recognized as critical factors in HTN disparities.

Purpose of the Study:

  • To review recent literature on the differential impact of hypertension on racial/ethnic minorities.
  • To highlight current research and concepts related to HTN and race/ethnicity.

Main Methods:

  • Literature review of recent studies on hypertension in racial/ethnic minorities.
  • Analysis of epidemiological research and genomic findings.

More Related Videos

Estimation of Nephron Number in Whole Kidney using the Acid Maceration Method
08:15

Estimation of Nephron Number in Whole Kidney using the Acid Maceration Method

Published on: May 22, 2019

10.5K
Simultaneous Electrocardiography Recording and Invasive Blood Pressure Measurement in Rats
07:35

Simultaneous Electrocardiography Recording and Invasive Blood Pressure Measurement in Rats

Published on: January 31, 2019

16.2K

Related Experiment Videos

Last Updated: Dec 21, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

1.1K
Estimation of Nephron Number in Whole Kidney using the Acid Maceration Method
08:15

Estimation of Nephron Number in Whole Kidney using the Acid Maceration Method

Published on: May 22, 2019

10.5K
Simultaneous Electrocardiography Recording and Invasive Blood Pressure Measurement in Rats
07:35

Simultaneous Electrocardiography Recording and Invasive Blood Pressure Measurement in Rats

Published on: January 31, 2019

16.2K
  • Examination of social determinants of health and intervention strategies.

    • Main Results:

    • Persistent disparities in HTN prevalence, control, and outcomes exist for racial/ethnic minorities compared to non-Hispanic Whites.
    • Genomic insights into HTN have not yet yielded clinically applicable solutions for disparities.
    • Team-based approaches and multilevel interventions show promise in overcoming barriers faced by minority populations.

    Conclusions:

    • Racial/ethnic minorities remain at elevated risk for HTN-related morbidity and mortality despite extensive research.
    • Translational research efforts are crucial to address the specific impacts of HTN in these populations.
    • Targeted, multilevel interventions are necessary to mitigate health disparities in hypertension.